Oversold Stocks In News: Halozyme Therapeutics (NASDAQ:HALO), Lumos Networks (NASDAQ:LMOS), Advaxis (NASDAQ:ADXS), Sterling Construction Company (NASDAQ:STRL)

Halozyme Therapeutics, Inc. (NASDAQ:HALO) reported that the U.S. Food and Drug Administration ordered a halt on a study of its drug delivery system in pancreatic cancer patients, barely a week after the company voluntarily stopped the trial. Halozyme Therapeutics, Inc. (NASDAQ:HALO) stock performance was -0.93% in last session and finished the day at $7.42. Traded volume was 3.20million shares in the last session and the … Continue reading Oversold Stocks In News: Halozyme Therapeutics (NASDAQ:HALO), Lumos Networks (NASDAQ:LMOS), Advaxis (NASDAQ:ADXS), Sterling Construction Company (NASDAQ:STRL)

Financial Sector Active Runners: Citigroup Inc (NYSE:C), Huntington Bancshares Incorporated (NASDAQ:HBAN), JPMorgan Chase (NYSE:JPM), Bank of America (NYSE:BAC)

At least two dozen bank employees have been fired, suspended or put on leave by banks from Citigroup Inc. (NYSE:C) to Barclays Plc amid probes into global currency markets. No firms or traders have been accused of wrongdoing. Citigroup Inc (NYSE:C) stock performance was -1.97% in last session and finished the day at $46.23. Traded volume was 27.17million shares in the last session and the … Continue reading Financial Sector Active Runners: Citigroup Inc (NYSE:C), Huntington Bancshares Incorporated (NASDAQ:HBAN), JPMorgan Chase (NYSE:JPM), Bank of America (NYSE:BAC)

Micro-cap unusual volume: OBA Financial Services (NASDAQ:OBAF), Investors Capital Holdings (NYSEMKT:ICH), Berkshire Bancorp (OTCMKTS:BERK), Consumer Portfolio Services (NASDAQ:CPSS)

Levi & Korsinsky is investigating the Board of Directors of OBA Financial Services Inc (NASDAQ:OBAF) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to F.N.B. Financial Services, Inc. (NYSE: FNB). OBA Financial Services Inc (NASDAQ:OBAF) stock performance was -0.40% in last session and finished the day at $22.40. Traded volume was 306,636.00million shares … Continue reading Micro-cap unusual volume: OBA Financial Services (NASDAQ:OBAF), Investors Capital Holdings (NYSEMKT:ICH), Berkshire Bancorp (OTCMKTS:BERK), Consumer Portfolio Services (NASDAQ:CPSS)

Services Sector Unusual Volume: Chico’s FAS (NYSE:CHS), Companhia Brasileira de Distrib (NYSE:CBD), Controladora Vuela (NYSE:VLRS), LivePerson, Inc. (NASDAQ:LPSN)

Chico’s FAS, Inc. (NYSE:CHS), the operator of more than 1,400 women’s clothing stores, rose the most in more than two years after Leonard Green & Partners LP disclosed a 1.3 percent stake in the company. Chico’s FAS, Inc. (NYSE:CHS) stock performance was 8.43% in last session and finished the day at $16.97. Traded volume was 11.76million shares in the last session and the average volume … Continue reading Services Sector Unusual Volume: Chico’s FAS (NYSE:CHS), Companhia Brasileira de Distrib (NYSE:CBD), Controladora Vuela (NYSE:VLRS), LivePerson, Inc. (NASDAQ:LPSN)

Industrial Goods Most Active Stocks: General Electric Company (NYSE:GE), Cemex SAB de (NYSE:CX), PulteGroup (NYSE:PHM), Weyerhaeuser Company (NYSE:WY)

Mark Bernardo, general manager of automation software at General Electric Company (NYSE:GE)’s Intelligent Platforms division, says moving to a new operating system can be extremely complicated and expensive for industrial companies. Bernardo, whose General Electric Company (NYSE:GE) division offers advisory services for upgrading from XP, says many of the unit’s customers fall into the fields of water and waste water, along with oil and gas. … Continue reading Industrial Goods Most Active Stocks: General Electric Company (NYSE:GE), Cemex SAB de (NYSE:CX), PulteGroup (NYSE:PHM), Weyerhaeuser Company (NYSE:WY)

Healthcare Most Active Stocks: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Teva Pharmaceutical Industries (NYSE:TEVA), Bristol-Myers Squibb (NYSE:BMY)

During the trial, palbociclib — a pill — was combined with the standard anti-estrogen treatment Letrozole. The combined treatment resulted in a 26.1 month progression-free survival rate compared with only 7.5 months for Letrozole alone. Under development by Pfizer Inc. (NYSE:PFE), the medication used in the study is a selective inhibitor of cyclin-dependent kinases (CDK) 4 and 6. Pfizer Inc. (NYSE:PFE) stock performance was -1.06% … Continue reading Healthcare Most Active Stocks: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Teva Pharmaceutical Industries (NYSE:TEVA), Bristol-Myers Squibb (NYSE:BMY)